Abstract
BackgroundAn association between lower neutrophil-to-eosinophil ratios (NER) and improved clinical outcomes in patients with metastatic renal cell carcinoma treated with combination ipilimumab/nivolumab (I/N) was recently reported.1 While neutrophil-to-lymphocyte ratios (NLR)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
